A combination of three treatments (canagliflozin, metformin, and fenugreek seed extract) reduced blood sugar by 57.8% and significantly improved bone structure in diabetic rats, according to a 2026 animal study. The three-drug combination outperformed any single treatment alone, reducing bone breakdown markers by 26-31% and strengthening the internal architecture of bones. While these results are promising, human studies are needed before this approach could be recommended for people with diabetes.

According to Gram Research analysis, scientists tested whether a combination of three treatments could help protect bones in diabetic rats. Diabetes damages bones by making them weaker and more fragile, but the study found that combining canagliflozin (a diabetes medication), metformin (another common diabetes drug), and fenugreek seed extract (a natural supplement) together worked better than any single treatment alone. After 12 weeks, the three-drug combination reduced blood sugar by nearly 58% and improved bone structure significantly. This research suggests that combining different types of treatments might help people with diabetes keep their bones stronger.

Key Statistics

A 2026 animal study found that combining canagliflozin, metformin, and fenugreek seed extract reduced fasting blood glucose by 57.8% and HbA1c by 47.4% in diabetic rats compared to untreated controls.

The three-drug combination therapy reduced serum TRAP activity (a bone breakdown marker) by 26.1% and urinary calcium excretion by 31.4% in diabetic rats, suggesting protection against diabetes-related bone loss.

In the 2026 study, the canagliflozin-metformin-fenugreek combination improved multiple measures of bone structure including trabecular thickness, trabecular number, and connectivity density in diabetic rats.

The Quick Take

  • What they studied: Whether combining three different diabetes treatments could protect bones from the damage that diabetes causes
  • Who participated: Female laboratory rats that were given diabetes through diet and injection, then treated with various drug combinations for 12 weeks
  • Key finding: The combination of all three treatments (canagliflozin, metformin, and fenugreek) reduced blood sugar by 57.8% and improved bone structure more than any single treatment
  • What it means for you: This early research suggests that combining multiple diabetes treatments might protect bones better than using one drug alone, but human studies are needed before doctors could recommend this approach

The Research Details

Researchers created diabetes in female rats by feeding them a high-fat diet and then injecting them with a chemical that damages the pancreas. Once the rats had diabetes, they divided them into groups and gave each group different treatments for 12 weeks. Some rats got canagliflozin alone at two different doses, some got fenugreek seed extract alone, and others got various combinations of all three treatments. The researchers measured blood sugar levels, bone quality, and bone-related chemicals in the blood and urine to see which treatments worked best.

This type of study is called a preclinical or animal study because it uses laboratory animals instead of people. Scientists use animal studies to test whether new treatment ideas are safe and effective before trying them in humans. The researchers chose female rats because they wanted to study how these treatments affect bones, and female rats are often used for bone research because their bone loss patterns are similar to what happens in women after menopause.

The study lasted 12 weeks, which is long enough to see significant changes in blood sugar control and bone structure in rats. The researchers used advanced imaging technology called micro-CT scanning to look at the detailed structure of the bones without cutting them open, and they also looked at bone samples under a microscope to confirm their findings.

This research matters because diabetes causes serious bone problems that doctors don’t have great treatments for yet. When blood sugar stays high for a long time, it damages the cells that build and break down bone, making bones weaker and more likely to break. Current diabetes medications focus mainly on lowering blood sugar, but they don’t always protect bones. By testing combinations of treatments, researchers can figure out whether using multiple drugs together might solve two problems at once: controlling blood sugar and protecting bones. This study is important because it suggests that combining different types of treatments might work better than using just one.

This study was conducted in a controlled laboratory setting with standardized procedures, which is good for reliability. The researchers used multiple ways to measure bone health (imaging, blood tests, urine tests, and microscope examination), which strengthens their findings. However, this is an animal study, so results may not directly apply to humans. The study was published in a peer-reviewed journal, meaning other scientists reviewed it before publication. The main limitation is that we don’t know yet whether these results would work the same way in people with diabetes.

What the Results Show

The combination of all three treatments (canagliflozin, metformin, and fenugreek) produced the strongest results. This combination reduced fasting blood sugar by approximately 57.8% compared to diabetic rats that received no treatment. It also reduced HbA1c (a measure of average blood sugar over time) by approximately 47.4%. These improvements in blood sugar control were accompanied by significant improvements in bone structure.

When researchers examined the bones using advanced imaging, they found that the combination treatment improved multiple measures of bone quality. The bones had better trabecular microarchitecture, which means the internal structure of the bones was stronger and more organized. Specifically, the treatment increased bone volume fraction (the amount of actual bone tissue), trabecular thickness (how thick the bone struts are), trabecular number (how many bone struts there are), and connectivity density (how well connected the bone structure is). The treatment also reduced trabecular separation (the gaps between bone struts) and structural model index (a measure of how fragile the bone structure is).

The researchers also measured chemicals in the blood and urine that indicate how much bone is being broken down. Serum TRAP activity (a marker of bone breakdown) was reduced by approximately 26.1%, and urinary calcium excretion (calcium lost in urine, which indicates bone loss) was reduced by approximately 31.4%. These reductions suggest that the combination treatment slowed down the excessive bone breakdown that occurs in diabetes.

When researchers looked at bone samples under a microscope, the findings matched what they saw in the imaging studies. The bones from rats treated with the combination therapy looked healthier and more normal compared to untreated diabetic rats.

Canagliflozin alone and fenugreek seed extract alone also showed benefits, but they were not as strong as the combination treatment. The two-drug combination of canagliflozin and metformin improved blood sugar control and bone structure, but adding fenugreek seed extract made the results even better. This suggests that each component of the treatment contributes something valuable, and combining them creates a stronger effect than any single treatment.

Previous research has shown that diabetes damages bones and increases fracture risk, but most diabetes medications focus only on lowering blood sugar. Some earlier studies suggested that certain natural compounds like fenugreek might have bone-protective effects, and some research indicated that canagliflozin (a newer type of diabetes drug) might have benefits beyond blood sugar control. This study is one of the first to systematically test whether combining these different approaches could provide better bone protection than any single treatment. The results support the idea that a multi-targeted approach might be more effective than treating just one aspect of diabetes.

This study was conducted in rats, not humans, so we cannot be certain the results would be the same in people. The study lasted 12 weeks, which is relatively short in human terms. The researchers did not test whether these treatments would work in male rats or in different types of diabetes. The study did not examine potential side effects or safety concerns with long-term use of these combinations. Additionally, the exact mechanisms by which these treatments protect bones were not fully explored. More research in humans would be needed before doctors could recommend these specific combinations as a treatment.

The Bottom Line

Based on this animal research, the combination of canagliflozin, metformin, and fenugreek seed extract shows promise for protecting bones in diabetes. However, this is early-stage research, and human studies are needed before this approach could be recommended for patients. If you have diabetes and are concerned about bone health, talk to your doctor about your current treatment plan and whether additional bone-protective measures might be appropriate for you. Do not start taking fenugreek or change your diabetes medications without consulting your healthcare provider.

This research is most relevant to people with type 2 diabetes who are concerned about bone health and fracture risk. It may also interest healthcare providers who treat diabetes and want to understand new approaches to protecting bones. Researchers studying diabetes complications and bone health should pay attention to these findings. People without diabetes do not need to act on this research at this time. This research is not yet applicable to clinical practice but suggests directions for future human studies.

In this animal study, significant improvements in blood sugar and bone structure were observed after 12 weeks of treatment. If similar treatments were tested in humans, it would likely take several months to see measurable improvements in blood sugar control, and bone changes might take even longer to become apparent. Any human studies would need to run for at least several months, and possibly years, to determine whether these treatments are safe and effective in people.

Frequently Asked Questions

Can fenugreek help protect bones in people with diabetes?

Animal research suggests fenugreek may help protect bones when combined with diabetes medications, but human studies haven’t been done yet. Talk to your doctor before taking fenugreek supplements, as they can interact with diabetes medications and affect blood sugar levels.

Does canagliflozin protect bones better than other diabetes drugs?

This study suggests canagliflozin combined with metformin and fenugreek works well for bone health in rats. However, this is early research in animals, not humans. Your doctor can discuss whether canagliflozin is appropriate for your individual diabetes management.

How long does it take to see bone improvements from diabetes treatment?

In this animal study, significant bone improvements appeared after 12 weeks. In humans, bone changes typically take months to become measurable. Blood sugar improvements usually happen faster than bone changes, often within weeks of starting treatment.

Why does diabetes damage bones?

High blood sugar disrupts the cells that build and break down bone, causing an imbalance where bone breaks down faster than it rebuilds. This makes bones weaker and more fragile, increasing fracture risk even though bone density might appear normal on some tests.

Should I ask my doctor about this combination treatment?

This is animal research, not yet proven in humans. Discuss your bone health concerns with your doctor, who can evaluate your individual risk factors and current medications. Don’t start new supplements without medical guidance, as they can interact with diabetes drugs.

Want to Apply This Research?

  • If you have diabetes, track your fasting blood sugar readings daily and record them in the app. Also track any bone-related symptoms like joint pain, muscle weakness, or falls. This creates a baseline to discuss with your doctor if combination therapies become available.
  • Work with your healthcare provider to optimize your current diabetes management through diet, exercise, and medication adherence. Use the app to log meals, physical activity, and medication timing. If your doctor recommends fenugreek or other supplements in the future, use the app to track compliance and any changes in blood sugar or bone health markers.
  • Set up monthly reminders to review your average blood sugar readings and any bone health concerns. Track weight changes, as weight affects bone health. Record any falls or injuries, as these may indicate bone fragility. Share this data with your healthcare provider at regular appointments to monitor your overall diabetes management and bone health.

This research was conducted in laboratory rats and has not been tested in humans. The findings do not yet constitute medical advice or recommendations for human treatment. People with diabetes should not change their medications or start new supplements based on this animal study without consulting their healthcare provider. Fenugreek and other supplements can interact with diabetes medications and affect blood sugar levels. Always discuss any new treatments or supplements with your doctor before use. This article is for educational purposes only and should not replace professional medical advice.

This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.

Source: Assessment of monotherapy and combination therapy with canagliflozin, metformin, and fenugreek seed extract in experimental diabetic osteopathy. , 3 Biotech (2026). PubMed 42802719 | DOI
Topics
diabetes bone health canagliflozin bone protection metformin fenugreek combination diabetic osteopathy treatment blood sugar control bone damage diabetes complications prevention natural diabetes remedies bone loss diabetes